Navigation Links
Clinical Trial Effectiveness: How Pharmas & Biotechs Save Cost with Savvy Investigator Management
Date:8/19/2007

CHAPEL HILL, N.C., Aug. 10 /PRNewswire/ -- More than 33% of pharmaceutical and biotech companies are able to identify clinical investigators 50% faster than their industry peers. These companies are able to significantly reduce clinical trial costs while improving quality by employing on-going relationship management tactics and centralized databases, according to research probing clinical trial excellence by pharmaceutical consulting firm Best Practices, LLC.

Best Practices LLC's Clinical Trial Excellence Series is a critical tool for executives searching for tactics to optimize their clinical trials. Developed from extensive surveys and interviews with executives at leading pharmaceutical, biotech and clinical research organizations, this series provides a detailed guide to ensuring faster and better clinical trial recruitment and retention.

Profiled in a complimentary download summary at http://www3.best-in-class.com/rr839.htm, research details findings such as:

-- The most valuable services for more than 70% of investigators are

patient recruitment funding and high-quality investigator meetings.

This is in sharp contrast to pharmaceutical and biotech companies

that said investigators most value study coordinator training and

phone support.

-- An adequate and reasonable budget is the most critical factor for

85% of interviewed clinical investigators.

-- The best companies develop and grow customer-relationship databases

with detailed investigator and site information to help jumpstart

study recruitment or entry into a new therapeutic area.

Benchmarked companies, including 3M Pharmaceuticals, Abbott Laboratories, Amgen, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, Merck, Novartis, Pfizer and Roche, have succeeded in:

-- Winning 50-80% higher investigator performance ratings than most

companies.

-- Commencing investigator selection and recruitment 3-6 months

earlier than average companies.

-- Identifying and recruiting investigators 2-4 times faster than

competitors in the benchmark class.

Download the complimentary excerpt of the Clinical Trial Excellence Series at http://www3.best-in-class.com/rr839.htm or contact our Solution Specialists at (919) 403-0251 or bestpractices@best-in-class.com for more information.

ABOUT BEST PRACTICES, LLC

Best Practices, LLC, conducts work based on the simple yet profound principle that organizations can chart a course to superior economic performance by studying the best business practices, operating tactics and winning strategies of world-class companies. Best Practices, LLC has been a leader in pharmaceutical research and consulting for nearly 15 years; our clients include 43 out of the top 50 pharmaceutical companies.


'/>"/>
SOURCE Best Practices, LLC

Copyright©2007 PR Newswire.

Related medicine technology :

1. Genetic Analysis Systems Enter the Clinical Mainstream
2. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
3. Large Geographic Differences in EpiPen Prescriptions in the U.S., From the Journal of Allergy and Clinical Immunology
4. Sygnis Pharma AG announces date for presentation of clinical results
5. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
6. Clinical Data Suggest Decreased Bleeding Risk in People With Severe Hemophilia A While Maintaining Factor VIII Levels Above One Percent
7. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
8. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
9. Corgenix Reports New Clinical Data Correlating AtherOx Technology With Vascular Disease
10. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
11. Protox Announces Positive Clinical Data from Prostate Cancer Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/9/2016)... Texas , Dec. 9, 2016  RxWiki Inc., ... apps, and digital marketing strategies of thousands of pharmacies ... it won Austin Inno,s "50 on Fire" ... "We,re pleased to accept the award as ... Loughlin , Chief Executive Officer at RxWiki. "Our platform ...
(Date:12/9/2016)... Dec. 9, 2016  Forge Therapeutics, Inc. today ... Stock Exchange: EVT, TecDAX, ISIN: DE0005664809) to advance ... the treatment of bacterial infections including those caused ... as an attractive antibacterial target for more than ... suitable chemical starting points has hampered its progress. ...
(Date:12/8/2016)... NEW YORK , Dec. 8, 2016 ... ... such as reducing loss of blood during surgeries, lowering the ... surgeries, and decreasing risks of SSIs. The patient warming systems ... and intravascular warming systems.These benefits in turn reduce the stay ...
Breaking Medicine Technology:
(Date:12/9/2016)... ... December 09, 2016 , ... MEDI+SIGN®, a provider of ... a new solution for Emergency Departments (ED) has been added to their portfolio. ... Department examination rooms, and with a simplified pallet of information available to the ...
(Date:12/8/2016)... ... December 08, 2016 , ... The West Virginia Medical Institute ... The name change aligns the entire company with its existing Quality Insights ... , “We are very proud of the achievements associated with the West Virginia ...
(Date:12/8/2016)... ... December 08, 2016 , ... Russ DiGilio , ... first national #QuackGivesBack campaign which supported local breast cancer organizations during National Breast ... Quack Gives Back initiative, and we’re very pleased with the participation in ...
(Date:12/8/2016)... , ... December 08, 2016 , ... ... offering Medication Therapy Management (MTM), adherence, and other pharmacist-delivered patient care services, has ... general counsel and Eric Hoessel to vice president of sales. , Litsinger ...
(Date:12/8/2016)... , ... December 08, 2016 , ... David J. ... global law firm Greenberg Traurig, LLP, will speak at DeviceTalks West, Dec. 12, 2016, ... the DeviceTalks series, and attorneys from the firm’s global Life Sciences & Medical Technology ...
Breaking Medicine News(10 mins):